Feedback / Questions
glycopyrrolate/indacaterol (AERO-007) - AeroRx Therapeutics
https://www.businesswire.com/news/home/20251007274842/en/AeroRx-Therapeutics-Announces-%2421-Million-Series-A-Financing-to-Advance-Inhaled-AERO-007-the-First-Nebulized-LABALAMA-for-COPD-into-Late-Stage-Clinical-Development
Oct 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next